Institutional investors purchased a net $1.7 million shares of PCYC during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 66.26% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HANDELSBANKEN FONDER AB Bought 2.4 Thousand shares of Pharmacyclics Inc
JOEL ISAACSON & CO. LLC Bought 500.00 shares of Pharmacyclics Inc
FIDEURAM ASSET MANAGEMENT (IRELA... Bought 351.00 shares of Pharmacyclics Inc